<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl12516</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-12516</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Иммуногистохимическое исследование экспрессии аберрантных/эутопических рецепторов у пациентов с макронодулярной гиперплазией надпочечников</article-title><trans-title-group xml:lang="en"><trans-title>Immunohistochemical study on the expression/hyperexpression of aberrant/eutopic receptors in patients with bilateral macronodular adrenal hyperplasia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5592-4794</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевэ</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chevais</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шевэ Анастасия.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN:2459-0540</p></bio><bio xml:lang="en"><p>Anastassia Chevais – MD.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN:2459-0540</p></bio><email xlink:type="simple">anastassia93@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6891-0009</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селиванова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Selivanova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Селиванова Лилия Сергеевна – кандидат медицинских наук.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 5151-3675</p></bio><bio xml:lang="en"><p>Liliya S. Selivanova - MD, PhD.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN: 5151-3675</p></bio><email xlink:type="simple">liselivanova89@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9419-7013</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецов</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetzov</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецов Николай Сергеевич - доктор медицинских наук, профессор.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 8412-1098</p></bio><bio xml:lang="en"><p>Nikolay S. Kuznetsov, MD, PhD, Professor.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN: 8412-1098</p></bio><email xlink:type="simple">kuznetsovnikolays@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2622-8858</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Деркач</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Derkatch</surname><given-names>D. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Деркач Дмитрий Анатольевич.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 9549-1557</p></bio><bio xml:lang="en"><p>Dmitriy A. Derkatch – MD.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN: 9549-1557</p></bio><email xlink:type="simple">dmitriy_derkatch@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8771-8300</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юкина</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Yukina</surname><given-names>M. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юкина Марина Юрьевна - кандидат медицинских наук.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN-код: 4963-8340</p></bio><bio xml:lang="en"><p>Marina Y. Yukina - MD, PhD.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN-код: 4963-8340</p></bio><email xlink:type="simple">kuronova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7098-4584</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бельцевич</surname><given-names>Д. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Beltsevich</surname><given-names>D. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бельцевич Дмитрий Германович - доктор медицинских наук, профессор.117036, Москва, ул. Дм. Ульянова, д. 11.eLibrary SPIN: 4475-6327</p></bio><bio xml:lang="en"><p>Dmitriy G. Beltsevich - MD, PhD, Professor.11 Dm. Ulyanova street, 117036, Moscow.eLibrary SPIN: 4475-6327</p></bio><email xlink:type="simple">belts67@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2020</year></pub-date><volume>66</volume><issue>6</issue><fpage>4</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шевэ А., Селиванова Л.С., Кузнецов Н.С., Деркач Д.А., Юкина М.Ю., Бельцевич Д.Г., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Шевэ А., Селиванова Л.С., Кузнецов Н.С., Деркач Д.А., Юкина М.Ю., Бельцевич Д.Г.</copyright-holder><copyright-holder xml:lang="en">Chevais A., Selivanova L.S., Kuznetzov N.S., Derkatch D.А., Yukina M.Y., Beltsevich D.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/12516">https://www.probl-endojournals.ru/jour/article/view/12516</self-uri><abstract><p>Макронодулярная двусторонняя гиперплазия надпочечников (МДГН) является редкой причиной развития синдрома Иценко–Кушинга. Продукция кортизола при данной патологии может регулироваться как генетическими факторами, так и различными молекулярными механизмами. Наличие аберрантных или гиперэкспрессия эутопических рецепторов на мембране клеток кортикального слоя надпочечников может приводить к активации цАМФ/­протеинкиназы А сигнального пути, что ведет к патологическому синтезу стероидных гормонов. Диагностика этого феномена с помощью предоперационных клинико-лабораторных тестов была признана нецелесообразной после доказательства эффективности односторонней адреналэктомии при МДГН, приводящей в большинстве случаев к длительной ремиссии гиперкортицизма. Тем не менее при отсутствии нормализации уровня кортизола в крови в послеоперационном периоде или при его рецидиве последующее консервативное лечение может быть предложено только в случае преобладания экспрессии/гиперэкспрессии тех или иных рецепторов. Их обнаружение становится возможным с помощью более надежных, чем клинико-лабораторные тесты, методов диагностики, таких как полимеразная цепная реакция (ПЦР) и иммуногистохимическое исследование (ИГХ), на данный момент широкое применение получил метод ПЦР-диагностики. В данной обзорной статье представлены накопленные данные о применении ИГХ при МДГН.</p></abstract><trans-abstract xml:lang="en"><p>Bilateral macronodular adrenal hyperplasia (BMAH) is a rare cause of Cushing’s syndrome. In this case cortisol production can be regulated by both genetic factors and various molecular mechanisms. The presence of aberrant or overexpression of eutopic receptors on the membrane of adrenal cortex may lead to activation of cAMP/PKA signaling pathways and consequently, pathological stimulation of steroidogenesis. Since proving the effectiveness of unilateral adrenalectomy in BMAH by achievement of stable remission, preoperative clinical and laboratory tests (ligand-induced tests) are no longer of relevant. Nevertheless, in the absence of normalization of the level of cortisol in the postoperative period or its recurrence, subsequent specific targeted medical options can be offered only if expression/hyperexpression predominance of one or another receptor. Their detection becomes possible using more reliable diagnostic methods such as polymerase chain reaction (PCR) and immunohistochemical studies (IHC) than clinical laboratory tests. At the moment, PCR has gained a wider application. This article summarizes data on the use of immunohistochemical study in BMAH.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>макронодулярная двусторонняя гиперплазия надпочечников</kwd><kwd>синдром Иценко–Кушинга</kwd><kwd>иммуногистохимическое исследование</kwd><kwd>диагностика мембранных рецепторов</kwd><kwd>аберрантные рецепторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Bilateral macronodular adrenal hyperplasia</kwd><kwd>Cushing’s Syndrome</kwd><kwd>immunohistochemical study</kwd><kwd>diagnostics of membrane’s receptors</kwd><kwd>aberrant receptors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fragoso MCBV, Pontes Cavalcante I, Meneses Ferreira A, et al. Genetics of primary macronodular adrenal hyperplasia. Press Medicale. 2018;47(7-8P2):139-149. doi: 10.1016/j.lpm.2018.07.002</mixed-citation><mixed-citation xml:lang="en">Fragoso MCBV, Pontes Cavalcante I, Meneses Ferreira A, et al. Genetics of primary macronodular adrenal hyperplasia. Press Medicale. 2018;47(7-8P2):139-149. doi: 10.1016/j.lpm.2018.07.002</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Espiard S, Drougat L, Libé R, et al. ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab. 2015;100(6):926-935. doi: 10.1210/jc.2014-4204</mixed-citation><mixed-citation xml:lang="en">Espiard S, Drougat L, Libé R, et al. ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J Clin Endocrinol Metab. 2015;100(6):926-935. doi: 10.1210/jc.2014-4204</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Assié G, Libé R, Espiard S, et al. ARMC5 mutations in macronodular adrenal hyperplasia with cushing’s syndrome. N Engl J Med. 2013;369(22):2105-2114. doi: 10.1056/NEJMoa1304603</mixed-citation><mixed-citation xml:lang="en">Assié G, Libé R, Espiard S, et al. ARMC5 mutations in macronodular adrenal hyperplasia with cushing’s syndrome. N Engl J Med. 2013;369(22):2105-2114. doi: 10.1056/NEJMoa1304603</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Stratakis CA. Cushing syndrome in pediatrics. Endocrinol Metab Clin North Am. 2012;41(4):793-803. doi: 10.1016/j.ecl.2012.08.002</mixed-citation><mixed-citation xml:lang="en">Stratakis CA. Cushing syndrome in pediatrics. Endocrinol Metab Clin North Am. 2012;41(4):793-803. doi: 10.1016/j.ecl.2012.08.002</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carney JA, Young WF, Stratakis CA. Primary bimorphic adrenocortical disease: Cause of hypercortisolism in mccune-albright syndrome. Am J Surg Pathol. 2011;35(9):1311-1326. doi: 10.1097/PAS.0b013e31821ec4ce</mixed-citation><mixed-citation xml:lang="en">Carney JA, Young WF, Stratakis CA. Primary bimorphic adrenocortical disease: Cause of hypercortisolism in mccune-albright syndrome. Am J Surg Pathol. 2011;35(9):1311-1326. doi: 10.1097/PAS.0b013e31821ec4ce</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lerario AM, Moraitis A, Hammer GD. Genetics and epigenetics of adrenocortical tumors. Mol Cell Endocrinol. 2014;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028</mixed-citation><mixed-citation xml:lang="en">Lerario AM, Moraitis A, Hammer GD. Genetics and epigenetics of adrenocortical tumors. Mol Cell Endocrinol. 2014;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshida M, Hiroi M, Imai T, et al. A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1. Endocr J. 2011;58(4):269-277. doi: 10.1507/endocrj.K10E-218</mixed-citation><mixed-citation xml:lang="en">Yoshida M, Hiroi M, Imai T, et al. A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1. Endocr J. 2011;58(4):269-277. doi: 10.1507/endocrj.K10E-218</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gaujoux S, Pinson S, Gimenez-Roqueplo AP, et al. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res. 2010;16(21):5133-5141. doi: 10.1158/1078-0432.CCR-10-1497</mixed-citation><mixed-citation xml:lang="en">Gaujoux S, Pinson S, Gimenez-Roqueplo AP, et al. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin Cancer Res. 2010;16(21):5133-5141. doi: 10.1158/1078-0432.CCR-10-1497</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A. Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;22(369):2147-2149. doi: 10.1056/NEJMe1312792</mixed-citation><mixed-citation xml:lang="en">Lacroix A. Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;22(369):2147-2149. doi: 10.1056/NEJMe1312792</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bourdeau I, Oble S, Magne F, et al. ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia. Eur J Endocrinol. 2016;174(1):85-96. doi: 10.1530/EJE-15-0642</mixed-citation><mixed-citation xml:lang="en">Bourdeau I, Oble S, Magne F, et al. ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia. Eur J Endocrinol. 2016;174(1):85-96. doi: 10.1530/EJE-15-0642</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Faucz FR, Zilbermint M, Lodish MB, et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) Gene: A clinical and genetic investigation. J Clin Endocrinol Metab. 2014;99(6):1113-1119. doi: 10.1210/jc.2013-4280</mixed-citation><mixed-citation xml:lang="en">Faucz FR, Zilbermint M, Lodish MB, et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) Gene: A clinical and genetic investigation. J Clin Endocrinol Metab. 2014;99(6):1113-1119. doi: 10.1210/jc.2013-4280</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vélayoudom-Céphise FL, Haissaguerre M, Tabarin A. Etiopathogeny of primary adrenal hypercortisolism. Front Horm Res. 2016;46:39-53. doi: 10.1159/000443863</mixed-citation><mixed-citation xml:lang="en">Vélayoudom-Céphise FL, Haissaguerre M, Tabarin A. Etiopathogeny of primary adrenal hypercortisolism. Front Horm Res. 2016;46:39-53. doi: 10.1159/000443863</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lefebvre H, Duparc C, Chartrel N, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2003;88(7):3035-3042. doi: 10.1210/jc.2002-030014</mixed-citation><mixed-citation xml:lang="en">Lefebvre H, Duparc C, Chartrel N, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2003;88(7):3035-3042. doi: 10.1210/jc.2002-030014</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Юкина М.Ю., Нуралиева Н.Ф., Бельцевич Д.Г., и др. Макронодулярная двусторонняя гиперплазия надпочечников: диагностика аберрантных рецепторов и современные аспекты лечения // Consilium Medicum. — 2016. — Т. 10. — С. 29-33. doi: 10.26442/2075-1753_2016.10.29-33</mixed-citation><mixed-citation xml:lang="en">Yukina MYu, Nuralieva NF, Beltsevich DG, et al. Macronodular bilateral adrenal hyperplasia: diagnose the aberrant receptors and current aspects of treatment. Consilium Medicum. 2016;18(10):29-33. (in Russ.). doi: 10.26442/2075-1753_2016.10.29-33</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Debillon E, Velayoudom-Cephise FL, Salenave S, et al. Unilateral adrenalectomy as a first-line treatment of cushing’s syndrome in patients with primary bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100(12):4417-4424. doi: 10.1210/jc.2015-2662</mixed-citation><mixed-citation xml:lang="en">Debillon E, Velayoudom-Cephise FL, Salenave S, et al. Unilateral adrenalectomy as a first-line treatment of cushing’s syndrome in patients with primary bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100(12):4417-4424. doi: 10.1210/jc.2015-2662</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Osswald A, Quinkler M, Di Dalmazi G, et al. Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia after Unilateral Adrenalectomy. J Clin Endocrinol Metab. 2019;104(7):2985-2993. doi: 10.1210/jc.2018-02204</mixed-citation><mixed-citation xml:lang="en">Osswald A, Quinkler M, Di Dalmazi G, et al. Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia after Unilateral Adrenalectomy. J Clin Endocrinol Metab. 2019;104(7):2985-2993. doi: 10.1210/jc.2018-02204</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sheikh-Ahmad M, Dickstein G, Matter I, et al. Unilateral Adrenalectomy for Primary Bilateral Macronodular Adrenal Hyperplasia: Analysis of 71 Cases. Exp Clin Endocrinol Diabetes. 2020;128(12):827-834. doi: https://doi.org/10.1055/a-0998-7884</mixed-citation><mixed-citation xml:lang="en">Sheikh-Ahmad M, Dickstein G, Matter I, et al. Unilateral Adrenalectomy for Primary Bilateral Macronodular Adrenal Hyperplasia: Analysis of 71 Cases. Exp Clin Endocrinol Diabetes. 2020;128(12):827-834. doi: https://doi.org/10.1055/a-0998-7884</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Albiger NM, Ceccato F, Zilio M, et al. An analysis of different therapeutic options in patients with Cushing’s syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience. Clin Endocrinol (Oxf). 2015;82(6):808-815. doi: 10.1111/cen.12763</mixed-citation><mixed-citation xml:lang="en">Albiger NM, Ceccato F, Zilio M, et al. An analysis of different therapeutic options in patients with Cushing’s syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience. Clin Endocrinol (Oxf). 2015;82(6):808-815. doi: 10.1111/cen.12763</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y, Rui W, Qi Y, et al. The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias. World J Surg. 2013;37(7):1626-1632. doi: 10.1007/s00268-013-2059-9</mixed-citation><mixed-citation xml:lang="en">Xu Y, Rui W, Qi Y, et al. The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias. World J Surg. 2013;37(7):1626-1632. doi: 10.1007/s00268-013-2059-9</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Terzolo M, Boccuzzi A, Ali A, et al. Cushing’s syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia. J Endocrinol Invest. 1997;20(5):270-275. doi: 10.1007/BF03350299</mixed-citation><mixed-citation xml:lang="en">Terzolo M, Boccuzzi A, Ali A, et al. Cushing’s syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia. J Endocrinol Invest. 1997;20(5):270-275. doi: 10.1007/BF03350299</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gu YL, Gu WJ, Dou JT, et al. Bilateral adrenocortical adenomas causing adrenocorticotropic hormone-independent Cushing’s syndrome: A case report and review of the literature. World J Clin Cases. 2019;7(8):961-971. doi: 10.12998/wjcc.v7.i8.961</mixed-citation><mixed-citation xml:lang="en">Gu YL, Gu WJ, Dou JT, et al. Bilateral adrenocortical adenomas causing adrenocorticotropic hormone-independent Cushing’s syndrome: A case report and review of the literature. World J Clin Cases. 2019;7(8):961-971. doi: 10.12998/wjcc.v7.i8.961</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing’s syndrome. Clin Endocrinol (Oxf). 2006;64(1):29-36. doi: 10.1111/j.1365-2265.2005.02411.x</mixed-citation><mixed-citation xml:lang="en">Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing’s syndrome. Clin Endocrinol (Oxf). 2006;64(1):29-36. doi: 10.1111/j.1365-2265.2005.02411.x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Vassiliadi DA, Tsagarakis S. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia. Endocr Relat Cancer. 2019;26(10):567-581. doi: 10.1530/ERC-19-0240</mixed-citation><mixed-citation xml:lang="en">Vassiliadi DA, Tsagarakis S. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia. Endocr Relat Cancer. 2019;26(10):567-581. doi: 10.1530/ERC-19-0240</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wada N, Kubo M, Kijima H, et al. Adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia: Immunohistochemical studies of steroidogenic enzymes and post-operative course in two men. Eur J Endocrinol. 1996;134(5):583-587. doi: 10.1530/eje.0.1340583</mixed-citation><mixed-citation xml:lang="en">Wada N, Kubo M, Kijima H, et al. Adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia: Immunohistochemical studies of steroidogenic enzymes and post-operative course in two men. Eur J Endocrinol. 1996;134(5):583-587. doi: 10.1530/eje.0.1340583</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Larose S, Bondaz L, Mermejo LM, et al. Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing’s Syndrome. Front Endocrinol (Lausanne). 2019;10(September):1-9. doi: 10.3389/fendo.2019.00618</mixed-citation><mixed-citation xml:lang="en">Larose S, Bondaz L, Mermejo LM, et al. Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing’s Syndrome. Front Endocrinol (Lausanne). 2019;10(September):1-9. doi: 10.3389/fendo.2019.00618</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">St-Jean M, Ghorayeb N El, Bourdeau I, Lacroix A. Aberrant G-protein coupled hormone receptor in adrenal diseases. Best Pract Res Clin Endocrinol Metab. 2018;32(2):165-187. doi: 10.1016/j.beem.2018.01.003</mixed-citation><mixed-citation xml:lang="en">St-Jean M, Ghorayeb N El, Bourdeau I, Lacroix A. Aberrant G-protein coupled hormone receptor in adrenal diseases. Best Pract Res Clin Endocrinol Metab. 2018;32(2):165-187. doi: 10.1016/j.beem.2018.01.003</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Schorr I, Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. J Clin Invest. 1971;50(6):1295-1300. doi: 10.1172/JCI106608</mixed-citation><mixed-citation xml:lang="en">Schorr I, Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase. J Clin Invest. 1971;50(6):1295-1300. doi: 10.1172/JCI106608</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">De Groot JWB, Links TP, Themmen APN, et al. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing’s syndrome. Eur J Endocrinol. 2010;163(2):293-299. doi: 10.1530/EJE-10-0058</mixed-citation><mixed-citation xml:lang="en">De Groot JWB, Links TP, Themmen APN, et al. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing’s syndrome. Eur J Endocrinol. 2010;163(2):293-299. doi: 10.1530/EJE-10-0058</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamura N, Taguchi T, Murata Y, et al. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: Detection of the aberrant hormone receptors on adrenal gland. Endocrine. 2002;19(3):319-325. doi: 10.1385/ENDO:19:3:319</mixed-citation><mixed-citation xml:lang="en">Miyamura N, Taguchi T, Murata Y, et al. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: Detection of the aberrant hormone receptors on adrenal gland. Endocrine. 2002;19(3):319-325. doi: 10.1385/ENDO:19:3:319</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A, Bourdeau I, Lampron A, et al. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf). 2010;73(1):1-15. doi: 10.1111/j.1365-2265.2009.03689.x</mixed-citation><mixed-citation xml:lang="en">Lacroix A, Bourdeau I, Lampron A, et al. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf). 2010;73(1):1-15. doi: 10.1111/j.1365-2265.2009.03689.x</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Libé R, Coste J, Guignat L, et al. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: A frequent finding in a prospective study of 32 patients with overt or subclinical Cushing’s syndrome. Eur J Endocrinol. 2010;163(1):129-138. doi: 10.1530/EJE-10-0195</mixed-citation><mixed-citation xml:lang="en">Libé R, Coste J, Guignat L, et al. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: A frequent finding in a prospective study of 32 patients with overt or subclinical Cushing’s syndrome. Eur J Endocrinol. 2010;163(1):129-138. doi: 10.1530/EJE-10-0195</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bornstein SR, Stratakis CA, Chrousos GP. Adrenocortical tumors: Recent advances in basic concepts and clinical management. Ann Intern Med. 1999;130(9):759-771. doi: 10.7326/0003-4819-130-9-199905040-00017</mixed-citation><mixed-citation xml:lang="en">Bornstein SR, Stratakis CA, Chrousos GP. Adrenocortical tumors: Recent advances in basic concepts and clinical management. Ann Intern Med. 1999;130(9):759-771. doi: 10.7326/0003-4819-130-9-199905040-00017</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Schorr I, Rathnam P, Saxena BB, Ney RL. Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma. J Biol Chem. 1971;246(18):5806-5811.</mixed-citation><mixed-citation xml:lang="en">Schorr I, Rathnam P, Saxena BB, Ney RL. Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma. J Biol Chem. 1971;246(18):5806-5811.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hirata Y, Uchihashi M, Sueoka S, et al. Presence of ectopic β-adrenergic receptors on human adrenocortical cortisol-producing adenomas. J Clin Endocrinol Metab. 1981;53(5):953-957. doi: 10.1210/jcem-53-5-953</mixed-citation><mixed-citation xml:lang="en">Hirata Y, Uchihashi M, Sueoka S, et al. Presence of ectopic β-adrenergic receptors on human adrenocortical cortisol-producing adenomas. J Clin Endocrinol Metab. 1981;53(5):953-957. doi: 10.1210/jcem-53-5-953</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Katz MS, Kelly TM, Dax EM, et al. Ectopic β-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. J Clin Endocrinol Metab. 1985;60(5):900-909. doi: 10.1210/jcem-60-5-900</mixed-citation><mixed-citation xml:lang="en">Katz MS, Kelly TM, Dax EM, et al. Ectopic β-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. J Clin Endocrinol Metab. 1985;60(5):900-909. doi: 10.1210/jcem-60-5-900</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cortez V, Santana M, Marques AP, et al. Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors. Neurochem Int. 2012;60(4):387-393. doi: 10.1016/j.neuint.2011.12.018</mixed-citation><mixed-citation xml:lang="en">Cortez V, Santana M, Marques AP, et al. Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors. Neurochem Int. 2012;60(4):387-393. doi: 10.1016/j.neuint.2011.12.018</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzuco TL, Thomas M, Martinie M, et al. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing’s syndrome. Arq Bras Endocrinol Metabol. 2007;51(9):1452-1462. doi: 10.1590/s0004-27302007000900007</mixed-citation><mixed-citation xml:lang="en">Mazzuco TL, Thomas M, Martinie M, et al. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing’s syndrome. Arq Bras Endocrinol Metabol. 2007;51(9):1452-1462. doi: 10.1590/s0004-27302007000900007</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Bertherat J, Contesse V, Louiset E, et al. In Vivo and in Vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing cushing’s syndrome: Identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab. 2005;90(3):1302-1310. doi: 10.1210/jc.2004-1256</mixed-citation><mixed-citation xml:lang="en">Bertherat J, Contesse V, Louiset E, et al. In Vivo and in Vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing cushing’s syndrome: Identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab. 2005;90(3):1302-1310. doi: 10.1210/jc.2004-1256</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Spagnolo EV, Mondello C, Cardia L, et al. Post-mortem immunohistochemical evidence of β2-adrenergic receptor expression in the adrenal gland. Int J Mol Sci. 2019;20(12):1-12. doi: 10.3390/ijms20123065</mixed-citation><mixed-citation xml:lang="en">Spagnolo EV, Mondello C, Cardia L, et al. Post-mortem immunohistochemical evidence of β2-adrenergic receptor expression in the adrenal gland. Int J Mol Sci. 2019;20(12):1-12. doi: 10.3390/ijms20123065</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Assie G, Louiset E, Sturm N, et al. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing’s syndrome. J Clin Endocrinol Metab. 2010;95(10):253-262. doi: 10.1210/jc.2009-2281</mixed-citation><mixed-citation xml:lang="en">Assie G, Louiset E, Sturm N, et al. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing’s syndrome. J Clin Endocrinol Metab. 2010;95(10):253-262. doi: 10.1210/jc.2009-2281</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Arnaldi G, de Keyzer Y, Gasc JM, et al. Vasopressin receptors modulate the pharmacological phenotypes of Cushing’s syndrome. Endocr Res. 1998;24(3-4):807-816. doi: 10.3109/07435809809032691</mixed-citation><mixed-citation xml:lang="en">Arnaldi G, de Keyzer Y, Gasc JM, et al. Vasopressin receptors modulate the pharmacological phenotypes of Cushing’s syndrome. Endocr Res. 1998;24(3-4):807-816. doi: 10.3109/07435809809032691</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki S, Uchida D, Koide H, et al. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s). Peptides. 2008;29(10):1767-1772. doi: 10.1016/j.peptides.2008.06.011</mixed-citation><mixed-citation xml:lang="en">Suzuki S, Uchida D, Koide H, et al. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s). Peptides. 2008;29(10):1767-1772. doi: 10.1016/j.peptides.2008.06.011</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S, Hwang R, Lee J, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf). 2005;63(6):625-630. doi: 10.1111/j.1365-2265.2005.02387.x</mixed-citation><mixed-citation xml:lang="en">Lee S, Hwang R, Lee J, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf). 2005;63(6):625-630. doi: 10.1111/j.1365-2265.2005.02387.x</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Gagliardi L, Hotu C, Casey G, et al. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds. Clin Endocrinol (Oxf). 2009;70(6):883-891. doi: 10.1111/j.1365-2265.2008.03471.x</mixed-citation><mixed-citation xml:lang="en">Gagliardi L, Hotu C, Casey G, et al. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds. Clin Endocrinol (Oxf). 2009;70(6):883-891. doi: 10.1111/j.1365-2265.2008.03471.x</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Vezzosi D, Carter D, Régnier C, et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol. 2007;156(1):21-31. doi: 10.1530/eje.1.02324</mixed-citation><mixed-citation xml:lang="en">Vezzosi D, Carter D, Régnier C, et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol. 2007;156(1):21-31. doi: 10.1530/eje.1.02324</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Arnaldi G, Gasc JM, De Keyzer Y, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab. 1998;83(6):2029-2035. doi: 10.1210/jc.83.6.2029</mixed-citation><mixed-citation xml:lang="en">Arnaldi G, Gasc JM, De Keyzer Y, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab. 1998;83(6):2029-2035. doi: 10.1210/jc.83.6.2029</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Mune T, Murase H, Yamakita N, et al. Eutopic overexpression of vasopressin V1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2002;87(12):5706-5713. doi: 10.1210/jc.2002-020067</mixed-citation><mixed-citation xml:lang="en">Mune T, Murase H, Yamakita N, et al. Eutopic overexpression of vasopressin V1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 2002;87(12):5706-5713. doi: 10.1210/jc.2002-020067</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing’s syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 1997;82(8):2414-2422. doi: 10.1210/jc.82.8.2414</mixed-citation><mixed-citation xml:lang="en">Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing’s syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 1997;82(8):2414-2422. doi: 10.1210/jc.82.8.2414</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Christopoulos S, Bourdeau I, Lacroix A. Aberrant expression of hormone receptors in adrenal Cushing’s syndrome. Pituitary. 2004;7(4):225-235. doi: 10.1007/s11102-005-1083-7</mixed-citation><mixed-citation xml:lang="en">Christopoulos S, Bourdeau I, Lacroix A. Aberrant expression of hormone receptors in adrenal Cushing’s syndrome. Pituitary. 2004;7(4):225-235. doi: 10.1007/s11102-005-1083-7</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Hofland J, Hofland LJ, Van Koetsveld PM, et al. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase. Orphanet J Rare Dis. 2013;8(1):1-12. doi: 10.1186/1750-1172-8-142</mixed-citation><mixed-citation xml:lang="en">Hofland J, Hofland LJ, Van Koetsveld PM, et al. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase. Orphanet J Rare Dis. 2013;8(1):1-12. doi: 10.1186/1750-1172-8-142</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Louiset E, Contesse V, Groussin L, et al. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing’s syndrome: Molecular, immunohistochemical and pharmacological correlates. J Endocrinol. 2008;196(1):1-9. doi: 10.1677/JOE-07-0413</mixed-citation><mixed-citation xml:lang="en">Louiset E, Contesse V, Groussin L, et al. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing’s syndrome: Molecular, immunohistochemical and pharmacological correlates. J Endocrinol. 2008;196(1):1-9. doi: 10.1677/JOE-07-0413</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">El Ghorayeb N, Bourdeau I, Lacroix A. Multiple aberrant hormone receptors in Cushing’s syndrome. Eur J Endocrinol. 2015;173(4):M45-M60. doi: 10.1530/EJE-15-0200</mixed-citation><mixed-citation xml:lang="en">El Ghorayeb N, Bourdeau I, Lacroix A. Multiple aberrant hormone receptors in Cushing’s syndrome. Eur J Endocrinol. 2015;173(4):M45-M60. doi: 10.1530/EJE-15-0200</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327(14):981-986. doi: 10.1056/NEJM199210013271403</mixed-citation><mixed-citation xml:lang="en">Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327(14):981-986. doi: 10.1056/NEJM199210013271403</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing’s syndrome. N Engl J Med. 1992;327(14):974-980. doi: 10.1056/NEJM199210013271402</mixed-citation><mixed-citation xml:lang="en">Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing’s syndrome. N Engl J Med. 1992;327(14):974-980. doi: 10.1056/NEJM199210013271402</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A. Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome: Clinical consequences. Endocr Rev. 2001;22(1):75-110. doi: 10.1016/S1575-0922(03)74541-0</mixed-citation><mixed-citation xml:lang="en">Lacroix A. Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome: Clinical consequences. Endocr Rev. 2001;22(1):75-110. doi: 10.1016/S1575-0922(03)74541-0</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Lecoq A, Bouligand J, Kamenický P, et al. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing’s syndrome Find the latest version : Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing’s syndrome. 2017;2(18):e92184. doi: 10.1172/jci.insight.92184</mixed-citation><mixed-citation xml:lang="en">Lecoq A, Bouligand J, Kamenický P, et al. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing’s syndrome Find the latest version : Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing’s syndrome. 2017;2(18):e92184. doi: 10.1172/jci.insight.92184</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Regazzo D, Barbot M, Scaroni C, et al. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes. Rev Endocr Metab Disord. 2020;21(1):165-183. doi:10.1007/s11154-019-09536-6</mixed-citation><mixed-citation xml:lang="en">Regazzo D, Barbot M, Scaroni C, et al. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes. Rev Endocr Metab Disord. 2020;21(1):165-183. doi:10.1007/s11154-019-09536-6</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Lampron A, Bourdeau I, Oble S, et al. Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metab. 2009;94(3):750-756. doi: 10.1210/jc.2008-1340</mixed-citation><mixed-citation xml:lang="en">Lampron A, Bourdeau I, Oble S, et al. Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metab. 2009;94(3):750-756. doi: 10.1210/jc.2008-1340</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Albiger NM, Occhi G, Mariniello B, et al. Food-dependent Cushing’s syndrome: From molecular characterization to therapeutical results. Eur J Endocrinol. 2007;157(6):771-778. doi:10.1530/EJE-07-0253</mixed-citation><mixed-citation xml:lang="en">Albiger NM, Occhi G, Mariniello B, et al. Food-dependent Cushing’s syndrome: From molecular characterization to therapeutical results. Eur J Endocrinol. 2007;157(6):771-778. doi:10.1530/EJE-07-0253</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Messidoro C, Elte JWF, Castro Cabezas M, et al. Food-dependent Cushing’s syndrome. Neth J Med. 2009;67(5):187-190.</mixed-citation><mixed-citation xml:lang="en">Messidoro C, Elte JWF, Castro Cabezas M, et al. Food-dependent Cushing’s syndrome. Neth J Med. 2009;67(5):187-190.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Chabre O, Liakos P, Vivier J, et al. Cushing’s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: Insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab. 1998;83(9):3134-3143. doi: 10.1210/jc.83.9.3134</mixed-citation><mixed-citation xml:lang="en">Chabre O, Liakos P, Vivier J, et al. Cushing’s syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: Insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab. 1998;83(9):3134-3143. doi: 10.1210/jc.83.9.3134</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">N’Diaye N, Hamet P, Tremblay J, et al. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 1999;84(8):2616-2622. doi: 10.1210/jc.84.8.2616</mixed-citation><mixed-citation xml:lang="en">N’Diaye N, Hamet P, Tremblay J, et al. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 1999;84(8):2616-2622. doi: 10.1210/jc.84.8.2616</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Groussin L, Perlemoine K, Contesse V, et al. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab. 2002;87(5):1980-1985. doi: 10.1210/jcem.87.5.8458</mixed-citation><mixed-citation xml:lang="en">Groussin L, Perlemoine K, Contesse V, et al. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab. 2002;87(5):1980-1985. doi: 10.1210/jcem.87.5.8458</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Mircescu H, Jilwan J, N’Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing’s syndrome? J Clin Endocrinol Metab. 2015;85(10):3531-3536. doi: 10.1210/jcem.85.10.6865</mixed-citation><mixed-citation xml:lang="en">Mircescu H, Jilwan J, N’Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing’s syndrome? J Clin Endocrinol Metab. 2015;85(10):3531-3536. doi: 10.1210/jcem.85.10.6865</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Imai T, Sarkar D, Shibata A, et al. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: Possible contribution for the autonomous production of cortisol. Ann Surg. 2001;234(1):85-91. doi: 10.1097/00000658-200107000-00013</mixed-citation><mixed-citation xml:lang="en">Imai T, Sarkar D, Shibata A, et al. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: Possible contribution for the autonomous production of cortisol. Ann Surg. 2001;234(1):85-91. doi: 10.1097/00000658-200107000-00013</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Beuschlein F, Fassnacht M, Klink A, et al. ACTH-receptor expression, regulation and role in adrenocortical tumor formation. Eur J Endocrinol. 2001;144(3):199-206. doi: 10.1530/eje.0.1440199</mixed-citation><mixed-citation xml:lang="en">Beuschlein F, Fassnacht M, Klink A, et al. ACTH-receptor expression, regulation and role in adrenocortical tumor formation. Eur J Endocrinol. 2001;144(3):199-206. doi: 10.1530/eje.0.1440199</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Lefebvre H, Duparc C, Prévost G, et al. Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism. Front Endocrinol (Lausanne). 2015;6:11-13. doi: 10.3389/fendo.2015.00034</mixed-citation><mixed-citation xml:lang="en">Lefebvre H, Duparc C, Prévost G, et al. Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism. Front Endocrinol (Lausanne). 2015;6:11-13. doi: 10.3389/fendo.2015.00034</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;369(22):2115-2125. doi: 10.1056/NEJMoa1215245</mixed-citation><mixed-citation xml:lang="en">Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;369(22):2115-2125. doi: 10.1056/NEJMoa1215245</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix A, Hamet P BJ. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing’s syndrome. N Engl J Med. 1999;341(21):1577-1581. doi: 10.1056/NEJM199911183412104</mixed-citation><mixed-citation xml:lang="en">Lacroix A, Hamet P BJ. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing’s syndrome. N Engl J Med. 1999;341(21):1577-1581. doi: 10.1056/NEJM199911183412104</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Bourdeau I, Amour PD, Hamet P, Boutin J. Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing’s Syndrome. J Clin Endocrinol Metab. 2001;86(11):5534-5540. doi: 10.1210/jcem.86.11.8062</mixed-citation><mixed-citation xml:lang="en">Bourdeau I, Amour PD, Hamet P, Boutin J. Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing’s Syndrome. J Clin Endocrinol Metab. 2001;86(11):5534-5540. doi: 10.1210/jcem.86.11.8062</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Cartier D, Lihrmann I, Parmentier F, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2003;88(1):248-254. doi:10.1210/jc.2002-021107</mixed-citation><mixed-citation xml:lang="en">Cartier D, Lihrmann I, Parmentier F, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2003;88(1):248-254. doi:10.1210/jc.2002-021107</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Mannelli M, Ferruzzi P, Luciani P, et al. Cushing’s syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to Cisapride: an in vivo and in vitro study. J Clin Endocrinol Metab. 2003;88(10):4616-4622. doi: 10.1210/jc.2002-021949</mixed-citation><mixed-citation xml:lang="en">Mannelli M, Ferruzzi P, Luciani P, et al. Cushing’s syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to Cisapride: an in vivo and in vitro study. J Clin Endocrinol Metab. 2003;88(10):4616-4622. doi: 10.1210/jc.2002-021949</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Lefebvre H, Duparc C, Prévost G, et al. Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms. Mol Cell Endocrinol. 2015;408:198-204. doi: 10.1016/j.mce.2014.11.013</mixed-citation><mixed-citation xml:lang="en">Lefebvre H, Duparc C, Prévost G, et al. Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms. Mol Cell Endocrinol. 2015;408:198-204. doi: 10.1016/j.mce.2014.11.013</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Louiset E, Contesse V, Groussin L, et al. Expression of serotonin 7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin- independent macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2006;91(11):4578-4586. doi: 10.1210/jc.2006-0538</mixed-citation><mixed-citation xml:lang="en">Louiset E, Contesse V, Groussin L, et al. Expression of serotonin 7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin- independent macronodular adrenal hyperplasia causing Cushing’s syndrome. J Clin Endocrinol Metab. 2006;91(11):4578-4586. doi: 10.1210/jc.2006-0538</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Roels H. The the effect and adrenal of some cortex pituitary in hormones nuclei on of volume content of cell hypophysectomized- castrated. Exp Cell Res. 1963;31:407-415. doi: 10.1016/0014-4827(63)90017-x</mixed-citation><mixed-citation xml:lang="en">Roels H. The the effect and adrenal of some cortex pituitary in hormones nuclei on of volume content of cell hypophysectomized- castrated. Exp Cell Res. 1963;31:407-415. doi: 10.1016/0014-4827(63)90017-x</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Mikolajczyk H, Pawlikowski T. Histologic changes in the adrenal cortex of hypophysectomized-gonadectomized rats treated with gonadotrophins or adrenocorticotrophin. Endokrynol Pol. 1965;16(4):359-69.</mixed-citation><mixed-citation xml:lang="en">Mikolajczyk H, Pawlikowski T. Histologic changes in the adrenal cortex of hypophysectomized-gonadectomized rats treated with gonadotrophins or adrenocorticotrophin. Endokrynol Pol. 1965;16(4):359-69.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Rilianawati, Paukku T, Kero J, et al. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 t-antigen fusion gene. Mol Endocrinol. 1998;12(6):801-809. doi: 10.1210/mend.12.6.0117</mixed-citation><mixed-citation xml:lang="en">Rilianawati, Paukku T, Kero J, et al. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 t-antigen fusion gene. Mol Endocrinol. 1998;12(6):801-809. doi: 10.1210/mend.12.6.0117</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Bertagna X, Groussin L, Luton JP, Bertherat J. Aberrant receptor-mediated Cushing’s syndrome. Horm Res. 2003;59(1):99-103. doi: 10.1159/000067832</mixed-citation><mixed-citation xml:lang="en">Bertagna X, Groussin L, Luton JP, Bertherat J. Aberrant receptor-mediated Cushing’s syndrome. Horm Res. 2003;59(1):99-103. doi: 10.1159/000067832</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Pabon JE, Li X, Lei ZM, Sanfilippo JS, et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab. 1996;81(6):2397-2400. doi: 10.1210/jc.81.6.2397</mixed-citation><mixed-citation xml:lang="en">Pabon JE, Li X, Lei ZM, Sanfilippo JS, et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab. 1996;81(6):2397-2400. doi: 10.1210/jc.81.6.2397</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Korol P, Jaranowska M, Pawlikowski M. Immunohistochemical demonstration of LH/CG receptors in non-neoplastic human adrenal cortex and adrenocortical tumors. Folia Histochem Cytobiol. 2019;57(1):23-27. doi: 10.5603/FHC.a2019.0003</mixed-citation><mixed-citation xml:lang="en">Korol P, Jaranowska M, Pawlikowski M. Immunohistochemical demonstration of LH/CG receptors in non-neoplastic human adrenal cortex and adrenocortical tumors. Folia Histochem Cytobiol. 2019;57(1):23-27. doi: 10.5603/FHC.a2019.0003</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Feelders RA, Lamberts SWJ, Hofland LJ, et al. Luteinizing hormone (LH)-responsive cushing’s syndrome: The demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J Clin Endocrinol Metab. 2003;88(1):230-237. doi: 10.1210/jc.2002-020621</mixed-citation><mixed-citation xml:lang="en">Feelders RA, Lamberts SWJ, Hofland LJ, et al. Luteinizing hormone (LH)-responsive cushing’s syndrome: The demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J Clin Endocrinol Metab. 2003;88(1):230-237. doi: 10.1210/jc.2002-020621</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
